CSafe launches transport packaging for gene therapy market

Pharma packaging firm CSafe Global has launched a new product for the cell and gene therapy market.

CSafe said the passive AcuTemp Plus Series of packaging solutions has been designed with “proprietary, high-performance ThermoCor Vacuum Insulated Panels (VIP) to guarantee precise end-to-end control of internal payload temperatures”. 

“We are proud to expand our cold chain packaging offerings for the cell and gene therapy market, and have focused and invested significantly in R&D to develop best-in-class solutions to meet the demanding product requirements for this emerging class of medication,” stated Patrick Schafer, chief executive of CSafe Global.

“Test results of the new AcuTemp Plus Series have been very impressive with temperature performances outlasting other market available solutions by a large margin.”